Literature DB >> 7903951

Genetic alterations at the splice junction of p53 gene in human hepatocellular carcinoma.

H C Hsu1, A M Huang, P L Lai, W M Chien, S Y Peng, S W Lin.   

Abstract

The tumor-suppressor gene p53 may transactivate the transcription of genes that down-regulate cellular growth-related genes and may become oncogenic as a result of the production of mutant proteins or the loss of its protein expression. This study reports that alterations of the highly conserved consensus intervening sequences at the splice junctions may lead to the inactivation of the p53 gene. Analyses with the combined polymerase chain reaction and single-strand conformational polymorphism and direct DNA sequencing of DNAs amplified by means of asymmetric polymerase chain reaction demonstrated sequence alterations at the splice junctions of introns 5 and 7 in four human hepatocellular carcinomas, with a single base substitution at the splice junction in three and a 10-bp deletion starting from the dinucleotide AG of the acceptor site of intron 5 in the fourth. Restriction fragment length polymorphism analysis disclosed allele loss in all three informative cases. The p53 mRNA concentrations were remarkably reduced or undetectable in two hepatocellular carcinomas, whereas the two tumors (cases 2 and 3) that had single base changes at the acceptor site of intron 7 had both normal and abnormally sized p53 mRNAs. Immunocytochemistry failed to detect the wild-type and mutant p53 proteins in all four tumors. Western-blot analysis disclosed an abnormal, larger p53 protein of 55 kD in the tumor of case 3.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7903951

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  7 in total

1.  Role of p53 and β-catenin mutations in conjunction with CK19 expression on early tumor recurrence and prognosis of hepatocellular carcinoma.

Authors:  Ray-Hwang Yuan; Yung-Ming Jeng; Rey-Heng Hu; Po-Lin Lai; Po-Huang Lee; Chia-Chi Cheng; Hey-Chi Hsu
Journal:  J Gastrointest Surg       Date:  2011-02       Impact factor: 3.452

2.  Expression of bile duct transcription factor HNF1β predicts early tumor recurrence and is a stage-independent prognostic factor in hepatocellular carcinoma.

Authors:  Ray-Hwang Yuan; Hong-Shiee Lai; Hey-Chi Hsu; Po-Lin Lai; Yung-Ming Jeng
Journal:  J Gastrointest Surg       Date:  2014-07-23       Impact factor: 3.452

3.  Overexpression of CTHRC1 in hepatocellular carcinoma promotes tumor invasion and predicts poor prognosis.

Authors:  Yu-Ling Chen; Ting-Huang Wang; Hey-Chi Hsu; Ray-Hwang Yuan; Yung-Ming Jeng
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

4.  Elevated preoperative serum CA19-9 levels in patients with hepatocellular carcinoma is associated with poor prognosis after resection.

Authors:  Yu-Ling Chen; Chien-Hung Chen; Rey-Heng Hu; Ming-Chih Ho; Yung-Ming Jeng
Journal:  ScientificWorldJournal       Date:  2013-06-12

5.  S100P expression is a novel prognostic factor in hepatocellular carcinoma and predicts survival in patients with high tumor stage or early recurrent tumors.

Authors:  Ray-Hwang Yuan; Ko-Tung Chang; Yu-Ling Chen; Hey-Chi Hsu; Po-Huang Lee; Po-Lin Lai; Yung-Ming Jeng
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

6.  Paradoxical overexpression of MBNL2 in hepatocellular carcinoma inhibits tumor growth and invasion.

Authors:  Yu-Hsin Lee; Yu-Lin Jhuang; Yu-Ling Chen; Yung-Ming Jeng; Ray-Hwang Yuan
Journal:  Oncotarget       Date:  2016-10-04

7.  Increased Trimethylation of histone H3K36 associates with biliary differentiation and predicts poor prognosis in resectable hepatocellular carcinoma.

Authors:  Huang-Chun Lien; Yung-Ming Jeng; Yu-Ling Jhuang; Ray-Hwang Yuan
Journal:  PLoS One       Date:  2018-10-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.